BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8747433)

  • 41. Molecular dynamics simulations of Gly-12-->Val mutant of p21(ras): dynamic inhibition mechanism.
    Futatsugi N; Tsuda M
    Biophys J; 2001 Dec; 81(6):3483-8. PubMed ID: 11721009
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structure and function of p21 ras proteins.
    Shih TY; Hattori S; Clanton DJ; Ulsh LS; Chen ZQ; Lautenberger JA; Papas TS
    Gene Amplif Anal; 1986; 4():53-72. PubMed ID: 3333361
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structure of a transient intermediate for GTP hydrolysis by ras.
    Ford B; Hornak V; Kleinman H; Nassar N
    Structure; 2006 Mar; 14(3):427-36. PubMed ID: 16531227
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regional polysterism in the GTP-bound form of the human c-Ha-Ras protein.
    Ito Y; Yamasaki K; Iwahara J; Terada T; Kamiya A; Shirouzu M; Muto Y; Kawai G; Yokoyama S; Laue ED; Wälchli M; Shibata T; Nishimura S; Miyazawa T
    Biochemistry; 1997 Jul; 36(30):9109-19. PubMed ID: 9230043
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Conformational Dynamics Allows Sampling of an "Active-like" State by Oncogenic K-Ras-GDP.
    Grudzien P; Jang H; Leschinsky N; Nussinov R; Gaponenko V
    J Mol Biol; 2022 Sep; 434(17):167695. PubMed ID: 35752212
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Why have mutagenesis studies not located the general base in ras p21.
    Schweins T; Langen R; Warshel A
    Nat Struct Biol; 1994 Jul; 1(7):476-84. PubMed ID: 7664067
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of oncogenic and activated wild-type ras-p21 protein-induced oocyte maturation by peptides from the guanine-nucleotide exchange protein, SOS, identified from molecular dynamics calculations. Selective inhibition of oncogenic ras-p21.
    Chie L; Chen JM; Friedman FK; Chung DL; Amar S; Michl J; Yamaizumi Z; Brandt-Rauf PW; Pincus MR
    J Protein Chem; 1999 Nov; 18(8):875-9. PubMed ID: 10839624
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structural insight into the rearrangement of the switch I region in GTP-bound G12A K-Ras.
    Xu S; Long BN; Boris GH; Chen A; Ni S; Kennedy MA
    Acta Crystallogr D Struct Biol; 2017 Dec; 73(Pt 12):970-984. PubMed ID: 29199977
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Simulation of the solution structure of the H-ras p21-GTP complex.
    Foley CK; Pedersen LG; Charifson PS; Darden TA; Wittinghofer A; Pai EF; Anderson MW
    Biochemistry; 1992 Jun; 31(21):4951-9. PubMed ID: 1599919
    [TBL] [Abstract][Full Text] [Related]  

  • 50. K-Ras Populates Conformational States Differently from Its Isoform H-Ras and Oncogenic Mutant K-RasG12D.
    Parker JA; Volmar AY; Pavlopoulos S; Mattos C
    Structure; 2018 Jun; 26(6):810-820.e4. PubMed ID: 29706533
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biological and structural characterization of a Ras transforming mutation at the phenylalanine-156 residue, which is conserved in all members of the Ras superfamily.
    Quilliam LA; Zhong S; Rabun KM; Carpenter JW; South TL; Der CJ; Campbell-Burk S
    Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1272-6. PubMed ID: 7877967
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The higher level of complexity of K-Ras4B activation at the membrane.
    Jang H; Banerjee A; Chavan TS; Lu S; Zhang J; Gaponenko V; Nussinov R
    FASEB J; 2016 Apr; 30(4):1643-55. PubMed ID: 26718888
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Affinity labeling of c-H-ras p21 consensus elements with periodate-oxidized GDP and GTP.
    Löw A; Sprinzl M; Faulhammer HG
    Eur J Biochem; 1993 Jul; 215(2):473-9. PubMed ID: 8393791
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Andrographolide derivatives inhibit guanine nucleotide exchange and abrogate oncogenic Ras function.
    Hocker HJ; Cho KJ; Chen CY; Rambahal N; Sagineedu SR; Shaari K; Stanslas J; Hancock JF; Gorfe AA
    Proc Natl Acad Sci U S A; 2013 Jun; 110(25):10201-6. PubMed ID: 23737504
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Solution structure and dynamics of ras p21.GDP determined by heteronuclear three- and four-dimensional NMR spectroscopy.
    Kraulis PJ; Domaille PJ; Campbell-Burk SL; Van Aken T; Laue ED
    Biochemistry; 1994 Mar; 33(12):3515-31. PubMed ID: 8142349
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of guanine nucleotide bound to ras protein in PC12 cells.
    Satoh T; Endo M; Nakamura S; Kaziro Y
    FEBS Lett; 1988 Aug; 236(1):185-9. PubMed ID: 3042464
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular switch for signal transduction: structural differences between active and inactive forms of protooncogenic ras proteins.
    Milburn MV; Tong L; deVos AM; Brünger A; Yamaizumi Z; Nishimura S; Kim SH
    Science; 1990 Feb; 247(4945):939-45. PubMed ID: 2406906
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro.
    Warne PH; Viciana PR; Downward J
    Nature; 1993 Jul; 364(6435):352-5. PubMed ID: 8332195
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ab initio study of the role of lysine 16 for the molecular switching mechanism of Ras protein p21.
    Futatsugi N; Hata M; Hoshino T; Tsuda M
    Biophys J; 1999 Dec; 77(6):3287-92. PubMed ID: 10585950
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of the active site of p21 ras by electron spin-echo envelope modulation spectroscopy with selective labeling: comparisons between GDP and GTP forms.
    Halkides CJ; Farrar CT; Larsen RG; Redfield AG; Singel DJ
    Biochemistry; 1994 Apr; 33(13):4019-35. PubMed ID: 8142406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.